OPT-200

N/A

Report date: 2025/01/26 16:00:50
NME

Base Information

Drug NameOPT-200
Drug Alias NameLipopolysaccharide inhibiting antibacterial (Oppilotech)OPT-200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipopolysaccharide (LPS) inhibitors
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOppilotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOppilotech Ltd
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A